Clinical Observation on Prognosis of 30 Cases of Diffuse Axonal Injury Intervened by Combination of Chinese and Western Medicine

Wang Shaojin~1; Qi Lanping~2

doi:10.13288/j.11-2166/r.2004.12.020

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Prognosis of 30 Cases of Diffuse Axonal Injury Intervened by Combination of Chinese and Western Medicine

更新时间：2021-11-20

- Clinical Observation on Prognosis of 30 Cases of Diffuse Axonal Injury Intervened by Combination of Chinese and Western Medicine
- Journal of Traditional Chinese Medicine Issue 12, Pages: 921-922(2004)
- 作者机构：
  
  1. 河北医科大学中医学院
  2. 河北医科大学第二医院石家庄市新石南路326号,050091
  3. 河北医科大学中医学院河北医科大学第二医院石家庄市新石南路326号,050091
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2004.12.020
  CLC： R651.15
- Published：2004
- 稿件说明：
移动端阅览
[1]王少锦,齐岚平.中西医结合疗法干预脑弥漫性轴索损伤预后30例临床观察[J].中医杂志,2004(12):921-922.

Wang Shaojin~1, Qi Lanping~2. Clinical Observation on Prognosis of 30 Cases of Diffuse Axonal Injury Intervened by Combination of Chinese and Western Medicine[J]. Journal of Traditional Chinese Medicine2004, (12): 921-922.
[1]王少锦,齐岚平.中西医结合疗法干预脑弥漫性轴索损伤预后30例临床观察[J].中医杂志,2004(12):921-922. DOI： 10.13288/j.11-2166/r.2004.12.020.

Wang Shaojin~1, Qi Lanping~2. Clinical Observation on Prognosis of 30 Cases of Diffuse Axonal Injury Intervened by Combination of Chinese and Western Medicine[J]. Journal of Traditional Chinese Medicine2004, (12): 921-922. DOI： 10.13288/j.11-2166/r.2004.12.020.

摘要

目的:观察安宫牛黄丸对脑弥漫性轴索损伤（DAI）预后的影响

探讨其应用于DAI患者后在催醒、降温等方面的作用。方法:将在西医常规治疗基础上加用安宫牛黄丸的DAI患者30例作为治疗组

与只进行西医常规治疗的DAI患者30例作对照

通过比较格拉斯哥昏迷量表（GCS）评分、格拉斯哥预后量表（GOS）评分和病死率

判断分析安宫牛黄丸对DAI预后的效果。结果:治疗组总有效率（80%）明显优于对照组（56.7%

P<0.05）

症状、体征较对照组有明显改善

GCS评分较对照组明显升高（P<0.01）

病死率下降

治疗组病死率为0

对照组为10%。结论:安宫牛黄丸在DAI治疗中具有明显的脑保护作用

疗效安全可靠

毒副作用小

使DAI预后趋于良性

具有一定的应用前景。

Abstract

Objective: To observe the effect of Angong Niuhuang Bolus on prognosis of diffuse axonal injury （DAI）

and to explore awaking and body-temperature-reducing actions of Angong Niuhuang Bolus in the patient of DAI. Methods: 30 cases of DAI were treated by routine western medicine therapy plus Angong Niuhuang Bolus as treatment group

and other 30 of DAI were treated by only routine western medicine therapy as control group. Their prognosis was estimated and analyzed by Glasgow Coma Scale（GCS）and Glasgow Outcome Scale（GOS）and mortality. Results:The total effective rate of 80% in the treatment group was significantly better than 56. 7% in the control group（P<0. 05）

and the symptoms and signs improved and GCS score increased significantly （P<0. 01）

and the mortality decreased in the treatment group as compared with the control group. Conclusion: Angong Niuhuang Bolus has obvious protecting action on the brain in the patient of DAI

with safe and credible therapeutic effect and less side effect.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Prognosis and Treatment of Systemic Lupus Erythematosus Based on Yin-Yang Toxin Theory

Influence of Pathogenesis "Stasis-heat" on the Pathological Condition and Prognosis of Cerebral Hemorrhage in Acute Stage

Relationship Between Chinese Medicine Syndrome and Prognosis of Sepsis Patients

Meta-analysis of Effects of Oral Administration of Chinese Patent Medicine on Major Adverse Cardiovascular and Cerebrovascular Events after PCI

Risk Factors,Clinical Characteristics and Prognosis in Ischemic Stroke Patients with Different Patterns of TCM Syndrome

Related Author

TANG Xiaopo

GUO Zilin

LIU Ruihua

SHAN Xueyan

ZHOU Xueping~2

XU Dan~1

ZHANG Lankun~1

GUO Weifeng~2

Related Institution

Guang'anmen Hospital，China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

Zhenjiang Municipal TCM Hospital

Changzhou Municipal TCM Hospital

Nanjing University of Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰